According to the results of a study conducted in Korea, breast cancer patients under the age of 35 have a worse prognosis than patients between the ages of 35 and 50, and may also be less responsive to tamoxifen (Nolvadex®). These results were published in the Journal of Clinical Oncology....
Read More...
[Source: Breast Cancer News]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment